Does anyone know anything about the new AD drug that is going through clinical
trials right now? It's called something like Salbelusol, and the short radio
report on it stated it was not a AChE inhibitor. The report had no other
useful info other than the usual scare tactic stuff about AD. I would
be very interested in whatever anyone knows.
Thank you in advance.
Kurt Kistler
